Tumour-derived microvesicles contain interleukin-8 and modulate production of chemokines by human monocytes

Anticancer Research

Volumn 31, Issue 4, 2011, Pages 1329-1335

  Baj Krzyworzeka, Monika ^a   Wȩglarczyk, Kazimierz ^a   Mytar, Bozenna ^a   Szatanek, Rafał ^a   Baran, Jarosław ^a   Zembala, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Chemokine; Microvesicles; Monocyte; Tumour

Indexed keywords

CUTANEOUS T CELL ATTRACTING CHEMOKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL4; HUMANS; INTERLEUKIN-8; MACROPHAGES; MICE; MICE, INBRED NOD; MICE, SCID; MICROVESSELS; MONOCYTES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79956102462     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Grage-Griebienow E, Flad HD and Ernst D: Heterogeneity of human peripheral blood monocytes subsets. J Leukoc Biol 69: 11-20, 2001.
2. Gordon S and Taylor PR: Monocyte aand macrophage heterogeneity. Nature Rev Immunol 5: 953-964, 2005.
3. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
4. Mantovani A, Bottazzi B, Colotta F, Sozani S and Ruco L: The origin and function of tumour associated macrophages. Immunol Today 13: 265-270, 1992.
5. Mytar B, Siedlar M, Woloszyn M, Collizzi V and Zembala M: Cross-talk between human monocytes and cancer cells during reactive oxygen intermediates generation the essential role of hyaluronan. Int J Cancer 94: 727-732, 2001. (Pubitemid 33035694)
6. Mytar B, Siedlar M, Woloszyn M, Ruggiero I, Pryjma J and Zembala M: Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. Br J Cancer 79: 737-743, 1999. (Pubitemid 29082098)
7. Mantovani A, Schioppa T, Porta C, Allavalena P and Sicca A: A role of tumour-associated macrophages in tumour progression and invasion. Cancer Metastasis Rev 25: 315-322, 2006. (Pubitemid 44922352)
8. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78, 2004.
9. Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K and Toi M: Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 92: 1085-1091, 2001. (Pubitemid 32861655)
10. Bottazzi B, Polentarutti N, Balsari A, Boraschi D, Ghezzi P, Salmona M and Mantovani A: Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumour cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer 31: 55-63, 1983. (Pubitemid 13179551)
11. Mantovani A, Sozzani S, Locati M, Allavalena P and Sicca A: Macrophage polarization Tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002. (Pubitemid 35223554)
12. Bingle L, Brown NJ and Lewis CE: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196: 254-265, 2002. (Pubitemid 34189413)
13. Nakayama Y, Nagashima N, Minagawa N, Inoue Y, Katsuki T, Onitsuka K, Sako T, Hirata K, Nagata N and Itoh H: Relationships between tumour-associated macrophages and clinicopathological factors in patients with colorectal cancer. Anticancer Res 22: 4291-4296, 2002. (Pubitemid 36134475)
14. Kasahara K, Strieter RM, Chensue SW, Standiford TJ and Kunkel SL: Mononuclear cell adherence induces neutrophil chemotactic factor/interleukin-8 gene expression. J Leukoc Biol 50: 287-295, 1991.
15. Matsushima K, Morishita, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ and Oppenheim JJ: Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumour necrosis factor. J Exp Med 167: 1883-1893, 1988.
16. Peveri P, Walz A, Dewald B and Baggiolini M: A novel neutrophil- activating factor produced by human mononuclear phagocytes. J Exp Med 167: 1547-1559, 1988.
17. Liebler JM, Kunkel SL, Burdick MD, Standiford TJ, Rolfe MW and Strieter RM: Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemagglutinin and lipopolysaccharide. J Immunol 152: 241-249, 1994.
18. Strieter RM, Belperio JA, Phillips RJ and Keane MP: CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 14: 195-200, 2004.
19. Hodge-Dufour J, Noble PW, Horton MR, Bao C, Wysoka M, Burdick MD, Strieter RM, Trinchieri G and Puré E: Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 159: 2492-2500, 1997. (Pubitemid 127681045)
20. Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, Czupryna A, Szczepanik A and Zembala M: Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 59: 841-850, 2010.
21. Baj-Krzyworzeka M, Szatanek R, Wȩglarczyk K, Baran J, Urbanowicz B, Brański P, Ratajczak MZ and Zembala M: Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immol Immunother 55: 808-818, 2006.
22. Dolo V, Ginestra A, Cassarà D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A and Vittorelli ML: Selective localization of matrix metalloproteinase 9, beta 1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 58: 4468-4474, 1998. (Pubitemid 28450053)
23. Entschieden F, Drell TL, Lang K, Masur K, Palm D, Bastian P, Niggemann B and Zaenker KS: Analysis methods of human cell migration. Exp Cell Res 307: 418-426, 2005. (Pubitemid 40799366)
24. Taylor DD and Gercel-Taylor C: Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer 92: 305-311, 2005. (Pubitemid 40343146)
25. Shedden K, Xie XT, Chandaroy P, Chang YT and Rosania GR: Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 63: 4331-4337, 2003. (Pubitemid 36950999)
26. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S and Rivoltini L: Tumour-released exosomes and their implicatons in cancer immunity. Cell Death Differ 15: 80-88, 2008. (Pubitemid 350286175)
27. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J and Zembala M: Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett 113: 76-82, 2007. (Pubitemid 47562121)
28. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS and Martin GR: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67: 519-528, 192.
29. Haslinger B, Mandl-Weber S, Sellmayer A and Sitter T: Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells. Cell Tissue Res 305: 79-86, 2001. (Pubitemid 32681870)
30. Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, Giavazzi R, Pavan A and Dolo V: Bioavailability of VEGF in tumour-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 8: 96-103, 2006.
31. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J and Ratajczak MZ: Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113: 752-760, 2005. (Pubitemid 40101256)
32. Mytar B, Woloszyn M, Szatanek R, Baj-Krzyworzeka M, Siedlar M, Ruggiero I, Wieckiewicz J and Zembala M: Tumour cell-induced deactivation of human monocytes. J Leukoc Biol 74: 1094-1101, 2003. (Pubitemid 38040331)
33. Wysoczynski M and Ratajczak MZ: Lung cancer-secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumours. Int J Cancer 125: 1595-1603, 2009.
34. Conti I and Rollins BJ: CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 14: 149-154, 2004. (Pubitemid 38586739)
35. Bae SY, Jung YJ, Woo SY, Park MH, Seoh JY and Ryu KH: Distinct locomotive patterns of granulocytes, monocytes and lymphocytes in a stable concentration gradient of chemokines. Int J Lab Hematol 30: 139-148, 2008. (Pubitemid 351365253)
36. Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP and Gho YS: Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 6: 4646-4655, 2007.
37. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B and Camussi G: Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110: 2440-2448, 2007. (Pubitemid 47523165)
38. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A and Ratajczak MZ: Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20: 1487-1495, 2006. (Pubitemid 44264090)